The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down more than 18% on Tuesday. Here’s what you need to know.

AI is reshaping life and business. Here’s why investors may want to consider simple ways to gain exposure to the booming AI ...

With REA Group reporting its earnings results tomorrow, investors may be wondering whether to buy shares ahead of that ...

Yielding close to 5%, this beaten-down S&P/ASX 200 Index (ASX: XJO) dividend stock looks well-placed to engineer a successful ...

Alongside the capital return, the ASX 200 share reaffirmed that it intends to pay an FY 2025 dividend of 18 cents per share, ...

These two ASX-listed exchange-traded funds (ETFs) look like great buys to me. Here’s why I’d own them for the long-term.

The ASX 200 works as a benchmark for the Australian market. Here are three thematic ASX ETFs that have beaten it so far this ...

Another ASX dividend stock that could be a buy is Super Retail. It is the owner of popular retail chains Supercheap Auto, ...

Internal conflict saw the Chairman resign. Here's how Bell Potter views Endeavour Group shares following this announcement.

The ResMed share price is nearing record territory after strong FY 2025 results, upbeat guidance, and a $150m buyback plan.

With the rise of AI, my portfolio is suddenly looking exciting. Here are the stocks that I hope will power my financial ...

Hub24 is another ASX share that UBS recently rated as a buy, with a current price target of $105.